Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-fv566 Total loading time: 0 Render date: 2024-07-19T12:15:27.702Z Has data issue: false hasContentIssue false

14 - Therapeutic decision making in BMT/SCT for soft tissue sarcomas

Published online by Cambridge University Press:  05 August 2013

By
Reinhold Munker ,
Vishwas Sakhalkar ,
Hillard M. Lazarus  and
Kerry Atkinson
Edited by
Reinhold Munker ,
Gerhard C. Hildebrandt ,
Hillard M. Lazarus  and
Kerry Atkinson
Reinhold Munker
Affiliation:
Louisiana State University, Shreveport
Gerhard C. Hildebrandt
Affiliation:
University of Utah
Hillard M. Lazarus
Affiliation:
Ireland Cancer Center, Case Western Reserve University Hospital, Cleveland
Kerry Atkinson
Affiliation:
University of Queensland
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
The BMT Data Book
Including Cellular Therapy
 , pp. 159 - 164
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Berthold, F, Boos, J, Burdach, S, et al. 2005. Myeloablative megatherapy with autologous stem cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomized controlled trial. Lancet Oncol 6: 649–658.CrossRefGoogle Scholar
Fish, JD & Grupp, SA. 2008. Stem cell transplantation for neuroblastoma. Bone Marrow Transplant 41: 159–165.CrossRefGoogle ScholarPubMed
Fraser, CJ, Weigel, BJ, Perentesis, JP, et al. 2006. Autologous stem cell transplantation for high-risk Ewing’s sarcoma and other pediatric solid tumors. Bone Marrow Transplant 37: 175–181.CrossRefGoogle ScholarPubMed
Grupp, SA, Asgharzadeh, S, & Yanik, GA. 2012. Neuroblastoma: issues in transplantation. Biol Blood Marrow Transplant 18: S92–S100.CrossRefGoogle ScholarPubMed
Kasper, B, Ho, AD, & Egerer, G. 2005. Is there an indication for high-dose chemotherapy in the treatment of bone and soft tissue sarcoma?Oncology 68: 115–121.CrossRefGoogle ScholarPubMed
Ladenstein, R, Pötschger, U, Le Deley, MC, et al. 2010. Primary disseminated multifocal Ewing sarcoma: results of the Euro-Ewing 99 trial. J Clin Oncol 28: 3284–3291.CrossRefGoogle Scholar
Laurence, V, Pierga, JY, Barthier, S, et al. 2005. Long-term follow-up of high-dose chemotherapy with autologous stem cell rescue in adults with Ewing tumor. Am J Clin Oncol 28: 301–309.CrossRefGoogle ScholarPubMed
Matthay, KK, Villablanca, JG, Seeger, RC, et al. 1999. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. N Engl J Med 341: 1165–1173.CrossRefGoogle ScholarPubMed
Matthay, KK, Yanik, G, Messina, J, et al. 2007. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma. J Clin Oncol 25: 1054–1060.CrossRefGoogle ScholarPubMed
Mc Tiernan, A, Driver, D, Michelagnoli, MOP, et al. 2006. High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing’s sarcoma family of tumours. Ann Oncol 17: 1301–1305.CrossRefGoogle Scholar
Meyers, PA. 2004. High-dose therapy with autologous stem cell rescue for pediatric sarcomas. Curr Opin Oncol 16: 120–125.CrossRefGoogle ScholarPubMed
Pedrazzoli, P, Ledermann, JA, Lotz, JP, et al. 2006. High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults. Ann Oncol 17: 1479–1488.CrossRefGoogle ScholarPubMed
Trahair, TN, Vowels, MR, Johnston, K, et al. 2007. Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation. Bone Marrow Transplant 40: 741–746.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×